164 related articles for article (PubMed ID: 3941540)
41. Surfactant-potentiated increases in intracranial pressure in a mouse model of Reye's syndrome.
Crocker JF; Lee SH; Love JA; Malatjalian DA; Renton KW; Rozee KR; Murphy MG
Exp Neurol; 1991 Jan; 111(1):95-7. PubMed ID: 1984438
[TBL] [Abstract][Full Text] [Related]
42. Carnitine, acylcarnitine and amino acid profiles analyzed by tandem mass spectrometry in a surfactant/virus mouse model of acute hepatic encephalopathy.
Murphy MG; Crocker JF; O'Regan P; Lee SH; Geldenhuys L; Dooley K; Al-Khalidi M; Acott PD
Chemosphere; 2007 Aug; 68(9):1692-8. PubMed ID: 17498775
[TBL] [Abstract][Full Text] [Related]
43. Two formulations of the industrial surfactant, Toximul, differentially reduce mouse weight gain and hepatic glycogen in vivo during early development: effects of exposure to Influenza B Virus.
Murphy MG; Al-Khalidi M; Crocker JF; Lee SH; O'Regan P; Acott PD
Chemosphere; 2005 Apr; 59(2):235-46. PubMed ID: 15722095
[TBL] [Abstract][Full Text] [Related]
44. Fatal case of Reye's syndrome associated with H3N2 influenza virus infection and salicylate intake in a 12-year-old patient.
Ninove L; Daniel L; Gallou J; Cougard PA; Charpentier A; Viard L; Roquelaure B; Paquis-Flucklinger V; de Lamballerie X; Zandotti C; Charrel RN
Clin Microbiol Infect; 2011 Jan; 17(1):95-7. PubMed ID: 20167009
[TBL] [Abstract][Full Text] [Related]
45. Interaction of the amino-terminus of an influenza virus protein with mitochondria.
Woodfin BM; Kazim AL
Arch Biochem Biophys; 1993 Nov; 306(2):427-30. PubMed ID: 8215446
[TBL] [Abstract][Full Text] [Related]
46. Role of the mitochondrial permeability transition in salicylate toxicity to cultured rat hepatocytes: implications for the pathogenesis of Reye's syndrome.
Trost LC; Lemasters JJ
Toxicol Appl Pharmacol; 1997 Dec; 147(2):431-41. PubMed ID: 9439738
[TBL] [Abstract][Full Text] [Related]
47. The ferret as a model for inner ear research.
Rarey KE
Lab Anim Sci; 1985 Jun; 35(3):238-41. PubMed ID: 4021437
[TBL] [Abstract][Full Text] [Related]
48. Potential for hepatic and renal dysfunction during influenza B infection, convalescence, and after induction of secondary viremia.
Kang ES; Lee HJ; Boulet J; Myers LK; Cook GA; Bean W
J Exp Pathol; 1992; 6(1-2):133-44. PubMed ID: 1352541
[TBL] [Abstract][Full Text] [Related]
49. Response of epithelial cells of the choroid plexus in the ferret model for Reye's syndrome.
Rarey KE; Davis JA; Deshmukh DR
Lab Invest; 1987 Mar; 56(3):249-55. PubMed ID: 3821066
[TBL] [Abstract][Full Text] [Related]
50. Effects of peroxidized polyunsaturated fatty acids on mitochondrial function and structure: pathogenetic implications for Reye's syndrome.
Brown RE; Bhuvaneswaran C; Brewster M
Ann Clin Lab Sci; 1988; 18(4):337-43. PubMed ID: 2900617
[TBL] [Abstract][Full Text] [Related]
51. Reye's and Reye's-like syndromes.
Pugliese A; Beltramo T; Torre D
Cell Biochem Funct; 2008 Oct; 26(7):741-6. PubMed ID: 18711704
[TBL] [Abstract][Full Text] [Related]
52. Reye's syndrome-like illness in a patient receiving amiodarone.
Jones DB; Mullick FG; Hoofnagle JH; Baranski B
Am J Gastroenterol; 1988 Sep; 83(9):967-9. PubMed ID: 3414648
[TBL] [Abstract][Full Text] [Related]
53. Animal models of Reye's syndrome.
Deshmukh DR
Rev Infect Dis; 1985; 7(1):31-40. PubMed ID: 3885365
[TBL] [Abstract][Full Text] [Related]
54. [Reye's syndrome].
Tomaszewski L
Pediatr Pol; 1982 Nov; 57(11):981-8. PubMed ID: 6763187
[No Abstract] [Full Text] [Related]
55. Free fatty acids in an animal model of Reye's syndrome.
Deshmukh DR; Deshmukh GD; Shope TC; Radin NS
Biochim Biophys Acta; 1983 Sep; 753(2):153-8. PubMed ID: 6615853
[TBL] [Abstract][Full Text] [Related]
56. Masking by enzyme inhibitor of raised serum glutamate dehydrogenase activity in Reye's syndrome.
Holt JT; Arvan DA; Mayer TK
Lancet; 1983 Jul; 2(8340):4-7. PubMed ID: 6134899
[TBL] [Abstract][Full Text] [Related]
57. Reduced activity of otc in the liver of a patient with Reye's syndrome.
Arashima S; Takekoshi Y; Anakura M; Nanbu H; Matsuda I
Adv Exp Med Biol; 1982; 153():163-70. PubMed ID: 7164895
[No Abstract] [Full Text] [Related]
58. [Etiological mechanism of Reye's syndrome--from the viewpoint of metabolic disorders].
Yoshida I; Yamashita F
Nihon Rinsho; 1984 Dec; 42(12):2824-36. PubMed ID: 6397640
[No Abstract] [Full Text] [Related]
59. Interaction between murine spf-ash mutation and genetic background yields different metabolic phenotypes.
Marini JC; Erez A; Castillo L; Lee B
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1764-71. PubMed ID: 17925451
[TBL] [Abstract][Full Text] [Related]
60. Aflatoxin and Reye's syndrome.
Stora C; Dvorackova I; Ayraud N
J Med; 1983; 14(1):47-54. PubMed ID: 6411848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
